Literature DB >> 14511809

Surface glycoprotein PSA (GP46) expression during short- and long-term culture of Leishmania chagasi.

Jeffrey K Beetham1, John E Donelson, Rebecca R Dahlin.   

Abstract

The mRNAs encoding promastigote surface antigen (PSA) of Leishmania chagasi have previously been shown to increase about 30-fold as in vitro cultured parasites progress from logarithmic to stationary phase, growth phases that are, respectively associated with parasites having low and high infectivity to mammals. Experiments reported here establish by western blot analysis that PSA proteins of 44 and 66 kDa also increase about 30-fold as parasite cultures reach stationary phase. Serial passage of parasite cultures resulted in a progressive reduction in PSA protein and RNA abundance to levels less than 3% that of cultures newly-initiated with parasites derived from a parasitized rodent. Loss of PSA mRNA abundance in serially passaged cells was not due to reduced PSA gene transcription rates, as determined by nuclear run-on assays. Neither was the loss associated with a marked decrease in PSA mRNA stability. Analysis of PSA RNA stability in the presence of actinomycin D, an inhibitor of transcription elongation, failed to detect a difference in fully processed cytosolic PSA mRNA stability regardless of the number of times a culture was passaged or the growth phase of the culture. Based on the lack of detectable difference in (cytosolic) mature PSA mRNA stability during promastigote development, the data indirectly suggest that the regulated expression of PSA in cells from low-passage cultures and the loss of PSA expression in high-passage cultures may be mediated by nuclear events that occur after transcription of the PSA genes and before arrival of the mature mRNAs in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511809     DOI: 10.1016/s0166-6851(03)00197-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes.

Authors:  Amanda E Ramer-Tait; Soi Meng Lei; Bryan H Bellaire; Jeffrey K Beetham
Journal:  J Parasitol       Date:  2012-06-04       Impact factor: 1.276

Review 2.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

3.  Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.

Authors:  Amel Ghouila; Fatma Z Guerfali; Chiraz Atri; Aymen Bali; Hanene Attia; Rabiaa M Sghaier; Ghada Mkannez; Nicholas J Dickens; Dhafer Laouini
Journal:  Infect Genet Evol       Date:  2016-11-04       Impact factor: 3.342

4.  Population changes in Leishmania chagasi promastigote developmental stages due to serial passage.

Authors:  Soi Meng Lei; Nathan M Romine; Jeffrey K Beetham
Journal:  J Parasitol       Date:  2010-08-13       Impact factor: 1.276

5.  Reduced hamster usage and stress in propagating Leishmania chagasi promastigotes using cryopreservation and saphenous vein inoculation.

Authors:  Soi Meng Lei; Amanda E Ramer-Tait; Rebecca R Dahlin-Laborde; Kathleen Mullin; Jeffrey K Beetham
Journal:  J Parasitol       Date:  2010-02       Impact factor: 1.276

6.  Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species.

Authors:  Frédéric Raymond; Sébastien Boisvert; Gaétan Roy; Jean-François Ritt; Danielle Légaré; Amandine Isnard; Mario Stanke; Martin Olivier; Michel J Tremblay; Barbara Papadopoulou; Marc Ouellette; Jacques Corbeil
Journal:  Nucleic Acids Res       Date:  2011-10-13       Impact factor: 16.971

7.  In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.

Authors:  Rym Chamakh-Ayari; Rachel Bras-Gonçalves; Narges Bahi-Jaber; Elodie Petitdidier; Wafa Markikou-Ouni; Karim Aoun; Javier Moreno; Eugenia Carrillo; Poonam Salotra; Himanshu Kaushal; Narender Singh Negi; Jorge Arevalo; Francesca Falconi-Agapito; Angela Privat; Maria Cruz; Julie Pagniez; Gérard-Marie Papierok; Faten Bel Haj Rhouma; Pilar Torres; Jean-Loup Lemesre; Mehdi Chenik; Amel Meddeb-Garnaoui
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

8.  Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle.

Authors:  Karine G Le Roch; Jeffrey R Johnson; Laurence Florens; Yingyao Zhou; Andrey Santrosyan; Munira Grainger; S Frank Yan; Kim C Williamson; Anthony A Holder; Daniel J Carucci; John R Yates; Elizabeth A Winzeler
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

9.  The promastigote surface antigen gene family of the Leishmania parasite: differential evolution by positive selection and recombination.

Authors:  Alain Devault; Anne-Laure Bañuls
Journal:  BMC Evol Biol       Date:  2008-10-24       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.